Orthopedic Implants Market Size, Share, and Trends 2025 to 2034

The global orthopedic implants market size accounted at USD 27.16 billion in 2025 and is predicted to surpass around USD 37.76 billion by 2034, representing a healthy CAGR of 3.73% between 2025 and 2034. The North America orthopedic implants market size was calculated at USD 13.88 billion in 2024 and is expected to grow at a fastest CAGR of 3.82% during the forecast year. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : May 2025
  • Report Code : 1884
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Orthopedic Implants Market 

5.1. COVID-19 Landscape: Orthopedic Implants Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Orthopedic Implants Market, By Product

8.1. Orthopedic Implants Market, by Product

8.1.1. Reconstructive Joint Replacements

8.1.1.1. Market Revenue and Forecast

8.1.2. Spinal Implants

8.1.2.1. Market Revenue and Forecast

8.1.3. Dental Implants

8.1.3.1. Market Revenue and Forecast

8.1.4. Trauma

8.1.4.1. Market Revenue and Forecast

8.1.5. Orthobiologics

8.1.5.1. Market Revenue and Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Orthopedic Implants Market, By Type

9.1. Orthopedic Implants Market, by Type

9.1.1. Wrist & Shoulder

9.1.1.1. Market Revenue and Forecast

9.1.2. Dental

9.1.2.1. Market Revenue and Forecast

9.1.3. Knee

9.1.3.1. Market Revenue and Forecast

9.1.4. Hip

9.1.4.1. Market Revenue and Forecast

9.1.5. Spine

9.1.5.1. Market Revenue and Forecast

9.1.6. Ankle

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Orthopedic Implants Market, By Biomaterial 

10.1. Orthopedic Implants Market, by Biomaterial

10.1.1. Metallic Biomaterials

10.1.1.1. Market Revenue and Forecast

10.1.2. Ceramic Biomaterials

10.1.2.1. Market Revenue and Forecast

10.1.3. Polymers Biomaterials

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Orthopedic Implants Market, By Procedure

11.1. Orthopedic Implants Market, by Procedure

11.1.1. Open Surgery

11.1.1.1. Market Revenue and Forecast

11.1.2. Minimally Invasive Surgery (MIS)

11.1.2.1. Market Revenue and Forecast

11.1.3. Others

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Orthopedic Implants Market, By End User

12.1. Orthopedic Implants Market, by End User

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast

12.1.2. Orthopedic Clinics

12.1.2.1. Market Revenue and Forecast

12.1.3. Home Cares

12.1.3.1. Market Revenue and Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global Orthopedic Implants Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product

13.1.2. Market Revenue and Forecast, by Type

13.1.3. Market Revenue and Forecast, by Biomaterial

13.1.4. Market Revenue and Forecast, by Procedure

13.1.5. Market Revenue and Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product

13.1.6.2. Market Revenue and Forecast, by Type

13.1.6.3. Market Revenue and Forecast, by Biomaterial

13.1.6.4. Market Revenue and Forecast, by Procedure

13.1.7. Market Revenue and Forecast, by End User  

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product

13.1.8.2. Market Revenue and Forecast, by Type

13.1.8.3. Market Revenue and Forecast, by Biomaterial

13.1.8.4. Market Revenue and Forecast, by Procedure

13.1.8.5. Market Revenue and Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product

13.2.2. Market Revenue and Forecast, by Type

13.2.3. Market Revenue and Forecast, by Biomaterial

13.2.4. Market Revenue and Forecast, by Procedure  

13.2.5. Market Revenue and Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product

13.2.6.2. Market Revenue and Forecast, by Type

13.2.6.3. Market Revenue and Forecast, by Biomaterial

13.2.7. Market Revenue and Forecast, by Procedure  

13.2.8. Market Revenue and Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product

13.2.9.2. Market Revenue and Forecast, by Type

13.2.9.3. Market Revenue and Forecast, by Biomaterial

13.2.10. Market Revenue and Forecast, by Procedure

13.2.11. Market Revenue and Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product

13.2.12.2. Market Revenue and Forecast, by Type

13.2.12.3. Market Revenue and Forecast, by Biomaterial

13.2.12.4. Market Revenue and Forecast, by Procedure

13.2.13. Market Revenue and Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product

13.2.14.2. Market Revenue and Forecast, by Type

13.2.14.3. Market Revenue and Forecast, by Biomaterial

13.2.14.4. Market Revenue and Forecast, by Procedure

13.2.15. Market Revenue and Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product

13.3.2. Market Revenue and Forecast, by Type

13.3.3. Market Revenue and Forecast, by Biomaterial

13.3.4. Market Revenue and Forecast, by Procedure

13.3.5. Market Revenue and Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product

13.3.6.2. Market Revenue and Forecast, by Type

13.3.6.3. Market Revenue and Forecast, by Biomaterial

13.3.6.4. Market Revenue and Forecast, by Procedure

13.3.7. Market Revenue and Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product

13.3.8.2. Market Revenue and Forecast, by Type

13.3.8.3. Market Revenue and Forecast, by Biomaterial

13.3.8.4. Market Revenue and Forecast, by Procedure

13.3.9. Market Revenue and Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product

13.3.10.2. Market Revenue and Forecast, by Type

13.3.10.3. Market Revenue and Forecast, by Biomaterial

13.3.10.4. Market Revenue and Forecast, by Procedure

13.3.10.5. Market Revenue and Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product

13.3.11.2. Market Revenue and Forecast, by Type

13.3.11.3. Market Revenue and Forecast, by Biomaterial

13.3.11.4. Market Revenue and Forecast, by Procedure

13.3.11.5. Market Revenue and Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product

13.4.2. Market Revenue and Forecast, by Type

13.4.3. Market Revenue and Forecast, by Biomaterial

13.4.4. Market Revenue and Forecast, by Procedure

13.4.5. Market Revenue and Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product

13.4.6.2. Market Revenue and Forecast, by Type

13.4.6.3. Market Revenue and Forecast, by Biomaterial

13.4.6.4. Market Revenue and Forecast, by Procedure

13.4.7. Market Revenue and Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product

13.4.8.2. Market Revenue and Forecast, by Type

13.4.8.3. Market Revenue and Forecast, by Biomaterial

13.4.8.4. Market Revenue and Forecast, by Procedure

13.4.9. Market Revenue and Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product

13.4.10.2. Market Revenue and Forecast, by Type

13.4.10.3. Market Revenue and Forecast, by Biomaterial

13.4.10.4. Market Revenue and Forecast, by Procedure

13.4.10.5. Market Revenue and Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product

13.4.11.2. Market Revenue and Forecast, by Type

13.4.11.3. Market Revenue and Forecast, by Biomaterial

13.4.11.4. Market Revenue and Forecast, by Procedure

13.4.11.5. Market Revenue and Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product

13.5.2. Market Revenue and Forecast, by Type

13.5.3. Market Revenue and Forecast, by Biomaterial

13.5.4. Market Revenue and Forecast, by Procedure

13.5.5. Market Revenue and Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product

13.5.6.2. Market Revenue and Forecast, by Type

13.5.6.3. Market Revenue and Forecast, by Biomaterial

13.5.6.4. Market Revenue and Forecast, by Procedure

13.5.7. Market Revenue and Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product

13.5.8.2. Market Revenue and Forecast, by Type

13.5.8.3. Market Revenue and Forecast, by Biomaterial

13.5.8.4. Market Revenue and Forecast, by Procedure

13.5.8.5. Market Revenue and Forecast, by End User

Chapter 14. Company Profiles

14.1. Zimmer Biomet Holdings

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Stryker Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Johnson & Johnson

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Medtronic Plc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. NuVasive

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Arthrex, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. DJO Finance LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Smith and Nephew Plc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. CONMED Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global orthopedic implant market size was accounted at USD 26.18 billion in 2024 and it is expected to reach around USD 37.76 billion by 2034.

The global orthopedic implant market is poised to grow at a CAGR of 3.73% from 2025 to 2034.

The major players operating in the orthopedic implant market are Zimmer Biomet Holdings, Stryker Corporation, Johnson & Johnson, Medtronic Plc, NuVasive, Arthrex, Inc., DJO Finance LLC, Smith and Nephew Plc., CONMED Corporation.

The cases of orthopedic disorders have increased in the recent times as a result of the faulty lifestyle practices followed by the people. The increasing cases of musculoskeletal diseases as respected the movement of the people which helps to boost the market growth

North America region will lead the global orthopedic implant market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client